News on ophthalmology and intraocular lenses
Eyedeal xPIB IOL
From June 1 to 2, the 2nd China-Uzbekistan Local Cooperation Forum was grandly held in the historic city of Samarkand.…
On April 27, the third day of the 2025 Annual Meeting of the American Society of Cataract and Refractive Surgery…
On the morning of April 26, the 51st Annual Meeting of the American Society of Cataract and Refractive Surgery (ASCRS)…
On April 25, the 51st Annual Meeting of the American Society of Cataract and Refractive Surgery (ASCRS 2025)…
From March 29 to 30, the 2025 Cataract Group Conference of Huaxia Eye Hospital Group placed a spotlight on a…
On March 27, Xi’an Eyedeal Medical Technology Co., Ltd. signed a strategic cooperation agreement with U.S.-based…
According to media reports, global ophthalmology leader Santen Pharmaceutical Co., Ltd. recently announced that the…
On December 24, the launch ceremony of the public welfare campaign — “Qiao Ai Xin · Light for Sight” Cataract IOL…
On December 7, the 8th Advanced Forum on Cataract and Glaucoma Developments hosted by the Ophthalmology Department of…
On November 21, the 27th Anniversary and 2024 Annual Commendation Conference of the Lifeline Express and China Lifeline…
On November 9, the 17th Joint Meeting of Japan-Korea-China Ophthalmologists was successfully held at Congrès Square…
From September 6th to 10th, the highly anticipated 42nd Annual Congress of the European Society of Cataract and…
The evolution of intraocular lens (IOL) materials has remained relatively stagnant for over 30 years. Recently,…
On August 12, Xi’an Eyedeal Medical Technology Co., Ltd. announced the donation of 5,000 high-performance intraocular…
Recently, at the 36th International Congress of German Ophthalmic Surgery held in Nuremberg, Germany, a scientific…
The year 2024 marks the 75th anniversary of the first intraocular lens (IOL) implantation surgery. On November 29,…
The development of biomedical materials is closely tied to human health and well-being, playing a critical role in…
Former FDA CDRH Director of Device Evaluation and Pantheon Vision President/CEO, Dr. John Sheets, recently visited…
On May 27, the 8th China-Japan-Korea Business Summit was held in Seoul, South Korea. The event was co-hosted by the…
Editor's Note: Polyisobutylene (PIB) is a flexible polymer that, when copolymerized with certain common monomers, can…
On December 15, 2023, Eyedeal successfully held the Clinical Trial Summary Meeting for its new-generation cross-linked…
From 2019 to 2021, Xi’an Eyedeal Medical Technology Co., Ltd. conducted a randomized, open-label, parallel-controlled…
On October 12 to 15, the 2023 Chinese Biomaterials Congress (CSBM2023) was held in Chongqing, China. Dr. Leonard…
Recently, at the 2023 Medical Device Product Innovation and International Cooperation Summit, Artery Network VB100…
Recently, Xi’an Eyedeal Medical Technology Co., Ltd. announced the successful completion of its Series B financing…
On April 18, Xi’an Eyedeal Medical Technology Co., Ltd. announced the successful completion of subject enrollment for…
On April 7, the KPMG China 2nd Biotech Innovation 50 Awards Ceremony was held simultaneously in Beijing, Shanghai, and…
Recently, the National Medical Products Administration (NMPA) announced the official market approval of a hydrophobic…
The American Academy of Ophthalmology (AAO) recently presented Professor Gerd U. Auffarth, scientific advisor of Xi’an…
Editor's note: Robert Ward, member of the Scientific Advisory Committee of Xi′an Eyedeal Medical Technology Co., Ltd.…
Xi’an Eyedeal Medical Technology announced that it completed the enrollment of its xPIB intraocular lens clinical trial…
Lately, the world-renowned "Edison Award" announced the winners of 2022. Robert Ward, Scientific Advisor of Xi’an…
Eyedeal Medical successfully held a press conference about the cross-linked polyolefin intraocular lens clinical trial…
International Conference on Medical Device Supervision and Administration From September 24 to 26, the 12th…
On November 4, Xi'an Science and Technology Bureau identified Xi'an Ophthalmology Biomaterials Engineering Technology…
On May 21, the official NMPA website announced that cross-linked polyisobutylene intraocular lenses declared by Xi'an…
The Human Resources and Social Security Department of Shaanxi Province has confirmed approval for Xi'an Eyedeal Medical…
On May 24 Xi'an Eyedeal Medical Technology Co., Ltd. hosted an event to launch its academician expert workstation.…
On January 24, the Organization Department of the Xi’an Municipal Committee of the Communist Party of China and the…
On November 5, Zhong Hongjiang, member of the Standing Committee of the Xi'an Municipal Party Committee, Secretary of…
The 2017 annual meeting of the "National Key R&D Program" led by Xi'an Eyedeal Medical Technology Co., Ltd. was held…
This interview was conducted October 13 at the National Key R&D Program key special project kick-off meeting and…
On October 13, Xi'an Eyedeal’s National Key R&D Program event was hosted by the China Biotechnology Development…